Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|March 7, 2000
New trends in thromboxane and prostacyclin modulatorsJ M Dogné, X de Leval, J Delarge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 10, 2000
Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancersD Waltregny, A Bellahcène, X de Leval, et al.
Current Medicinal Chemistry|July 27, 2000
Recent advances in inducible cyclooxygenase (COX-2) inhibitionX de Leval, J Delarge, F Somers, et al.
Journal De Pharmacie De Belgique|August 4, 1999
Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative studyX de Leval, J M Dogné, P Neven, et al.
Journal De Pharmacie De Belgique|June 25, 1999
BM 144: an original thromboxane A2 receptor antagonist derived from torasemideJ M Dogné, P Neven, J Damas, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 7, 2000
Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet functionJ M Dogné, X de Leval, P Neven, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 15, 2001
In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediatorsY Henrotin, X de Leval, M Mathy-Hartet, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationX de Leval, V Benoit, J Delarge, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet functionJ M Dogné, X de Leval, P Kolh, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 22, 2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole bloodX de Leval, J Delarge, P Devel, et al.
Pageof 2